Intended Audience Medical and Nursing, Scientists, Pharmacists, Governance, Research, Lab Further information Fee FREE TO ATTEND* (T&C’s apply) Register www.www.christie.nhs.uk/soo- events Email [email protected]Call 0161 918 7409 * Please note that if you book a place and fail to attend without giving at least 7 days notice of cancellation, a £20 cancellation fee will be applied. An Overview of Advanced Therapies: The UK landscape Tuesday 22nd October 2019 Education Centre (Dept 17), The Christie, Manchester, M20 4BX Topics Covered Malignant indications Non Malignant Indications Patient experience Manufacturing issues Commissioning of ATMPs Governance and Education Toxicity Management Overview An overview of the current issues in the development and delivery of Advanced Therapies, Cell and Gene Therapy, Adoptive Cell Therapies and iMATCH. This study day will increase knowledge on the clinical indications of Advanced Therapies. Delegates will gain an understanding of the complexities of delivering Advanced Therapies in an NHS setting. This will increase awareness of the patient experience and perspective of Advanced Therapy Medicinal Products. Follow us:
3
Embed
An Overview of Advanced Therapies: The UK landscape · An overview of the current issues in the development and delivery of Advanced Therapies, Cell and Gene Therapy, Adoptive Cell
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Intended Audience
Medical and Nursing, Scientists, Pharmacists,
Governance, Research, Lab
Further information
Fee FREE TO ATTEND* (T&C’s apply) Register www.www.christie.nhs.uk/soo-
events Email [email protected] Call 0161 918 7409 * Please note that if you book a place and fail to attend without giving at least 7 days notice of cancellation, a £20 cancellation fee will be applied.
An Overview of Advanced Therapies: The UK landscape
Tuesday 22nd October 2019 Education Centre (Dept 17), The Christie, Manchester, M20 4BX
Topics Covered
Malignant indications
Non Malignant Indications
Patient experience
Manufacturing issues
Commissioning of
ATMPs
Governance and Education
Toxicity Management
Overview
An overview of the current issues in the development and delivery of Advanced Therapies, Cell and Gene Therapy, Adoptive Cell Therapies and iMATCH. This study day will increase knowledge on the clinical indications of Advanced Therapies. Delegates will gain an understanding of the complexities of delivering Advanced Therapies in an NHS setting. This will increase awareness of the patient experience and perspective of Advanced Therapy Medicinal Products.